本文へ移動
cccskills
無料GitHub で公開

pdm-postpartum-endocrine-care

Recommends postpartum endocrine care (diabetes management) in addition to usual obstetric care for individuals with preexisting diabetes (including those with pregnancy loss or termination). Triggered by postpartum care planning for patients with diabetes after delivery.

インストール方法を見る

含まれるファイル(1)

  • SKILL.md3.0 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Postpartum endocrine care in addition to usual obstetric care for preexisting diabetes

STEP 1 — Gather Information

Collect recent glucose logs, HbA1c, current insulin regimen (type/dose), breastfeeding intentions, contraception plans, weight, blood pressure, renal function, thyroid studies, and depression screen.
Action: Document all data to inform postpartum diabetes management.

STEP 2 — Rule In / Rule Out

Determine if the patient has preexisting diabetes (type 1 or type 2) versus gestational diabetes only.
Decision: If preexisting diabetes is present (including pregnancy loss or termination), proceed to endocrine care; if only gestational diabetes, continue usual obstetric care without additional endocrine focus.

STEP 3 — Classify or Stratify

Stratify by diabetes type (T1DM vs T2DM) and current glycemic control (HbA1c <7% vs ≥7%) to guide insulin adjustments and monitoring intensity.
Action: Classify the patient to tailor postpartum insulin targets and follow‑up frequency.

STEP 4 — Decide

Initiate postpartum endocrine care: adjust insulin to meet fasting <95 mg/dL, 1‑hr postprandial <140 mg/dL, 2‑hr postprandial <120 mg/dL; provide breastfeeding support; discuss contraception; schedule multidisciplinary follow‑up (endocrinology, diabetes educator, obstetrics) within 2‑6 weeks postpartum.
Action: Implement the individualized postpartum diabetes management plan.

Clinical Guardrails / Mimics / Pitfalls

  • Do not delay endocrine care pending obstetric visit; prioritize glycemic management immediately postpartum.
  • Avoid abrupt insulin discontinuation; monitor for hypoglycemia, especially during breastfeeding or reduced intake.
  • Do not rely solely on obstetric providers for diabetes titration; involve endocrinology/diabetes education specialists.
  • Do not overlook contraception planning; postpartum period overlaps with preconception care.
  • Avoid ignoring mental health; screen for depression and diabetes distress.

Concrete Clinical Example

A 32‑year‑old woman with type 1 diabetes delivers vaginally at 39 weeks. On postpartum day 1 she reports breastfeeding and notes a 50% drop in insulin needs. She is advised to reduce basal insulin by 50%, check glucose pre‑meals and bedtime, and target fasting 70‑95 mg/dL, 1‑hr postprandial <140 mg/dL, 2‑hr postprandial <120 mg/dL. She is referred to endocrinology and a diabetes educator for follow‑up at 2 weeks postpartum and receives contraception counseling.

Source: Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline, Endocrine Society/European Society of Endocrinology, 2025, DOI: 10.1210/clinem/dgaf288

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する